Results 91 to 100 of about 32,355 (207)

Subtle Cardiovascular Dysfunction in the Unilateral 6-Hydroxydopamine-Lesioned Rat

open access: yesParkinson's Disease, 2010
The present study evaluated whether the unilateral 6-hydroxydopamine (6-OHDA) model of Parkinson's disease produces autonomic deficits. Autonomic parameters were assessed by implanting a small radiofrequency telemetry device which measured heart rate ...
K. Slack   +5 more
doaj   +1 more source

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease

open access: yesNeurobiology of Disease, 2005
Cannabinoids have been reported to provide neuroprotection in acute and chronic neurodegeneration. In this study, we examined whether they are also effective against the toxicity caused by 6-hydroxydopamine, both in vivo and in vitro, which may be ...
Isabel Lastres-Becker   +4 more
doaj   +1 more source

اثرات محافظتی عصاره گل گياه ازگيل ژاپنی بر سطوح MANF ساقه مغز در برابر سم 6- هيدروکسی دوپامين در رت [PDF]

open access: yes, 2014
زمينه و هدف : استرس اکسايشی در آبشار منتهی به تحليل نورون دوپامينی در بيماری پارکينسون، مشارکت دارد. عصاره هيدروالکی گل گياه ازگيل ژاپنی غنی از ترکيبات فنولی است.
آقاسی, محمد   +2 more
core  

alpha-lipoic acid suppresses 6-hydroxydoparnine-induced ROS generation and apoptosis through the stimulation of glutathione synthesis but not by the expression of heme oxygenase-1 [PDF]

open access: yes, 2008
We previously reported that the generation of reactive oxygen species (ROS) is the initial event in cell death induced by 6-hydroxydopamine (6-OHDA), an experimental model of Parkinsonism.
Akagi, Reiko   +9 more
core   +1 more source

RING finger protein 11 (RNF11) modulates susceptibility to 6-OHDA-induced nigral degeneration and behavioral deficits through NF-κB signaling in dopaminergic cells

open access: yesNeurobiology of Disease, 2013
Chronic activation of the NF-κB pathway is associated with progressive neurodegeneration in Parkinson's disease (PD). Given the role of neuronal RING finger protein 11 (RNF11) as a negative regulator of the NF-κB pathway, in this report we investigated ...
Elaine L. Pranski   +9 more
doaj   +1 more source

Romidepsin induces caspase-dependent cell death in human neuroblastoma cells [PDF]

open access: yes, 2017
Neuroblastoma is the most common extracranial pediatric solid tumor, arising from the embryonic sympathoadrenal lineage of the neural crest, and is responsible for 15% of childhood cancer deaths.
Hegarty, Shane V.   +5 more
core   +1 more source

6-hydroxydopamine (6-OHDA) Oxidative Stress Assay for Observing Dopaminergic Neuron Loss in Caenorhabditis elegans

open access: yesBio-Protocol, 2018
The nematode Caenorhabditis elegans is a powerful genetic model that can be used to investigate neuronal death. Research using C. elegans has been crucial to characterize cell death programmes that are conserved in mammals.
Sarah-Lena Offenburger, Anton Gartner
doaj   +1 more source

Effects of bacterial lipopolysaccharide exposure on immune responsiveness in a rodent model of Parkinson’s disease [PDF]

open access: yes, 2011
The effects of lipopolysaccharide (LPS) on immune modulation in rats subjected to a right-unilateral lesion of the substantia nigra neurons by means of 6-hydroxydopamine (6-OHDA), were investigated.
Ciobica A.   +4 more
core   +1 more source

Neuronal entropy depends on the level of alertness in the parkinsonian globus pallidus in vivo [PDF]

open access: yes, 2014
A new working hypothesis of Parkinson's disease (PD) proposes to focus on the central role of entropy increase in the basal ganglia (BG) in movement disorders. The conditions necessary for entropy increase in vivo are, however, still not fully described.
Andres, Daniela Sabrina   +3 more
core   +3 more sources

Transcriptional alterations under continuous or pulsatile dopaminergic treatment in dyskinetic rats [PDF]

open access: yes, 2018
Continuous dopaminergic treatment is considered to prevent or delay the occurrence of dyskinesia in patients with Parkinson's disease (PD). Rotigotine is a non-ergolinic D3>D2>D1 dopamine-receptor agonist for the treatment of PD using a transdermal ...
Gerlach, M.   +4 more
core  

Home - About - Disclaimer - Privacy